Novartis Hits Zydus With Patent Suit Over Dementia Patch

By Linda Chiem ( August 28, 2014, 5:15 PM EDT) -- Novartis AG slapped Zydus Pharmaceuticals (USA) Inc. with patent infringement suits in Delaware and New Jersey federal courts on Wednesday, claiming Zydus' proposed generic version of the Exelon patch, which is used to treat Alzheimer's disease and dementia, infringes on Novartis' patents....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!